M Pharm Drug Regulatory Affairs (M Pharm Drug Regulatory Affairs)
The course emphasizes on the technical and practical aspects of regulatory and quality compliance in the pharmaceutical industry. It is the centre of research and development (R and D). The candidates are provided a strong foundation in national and international drug approvals and bioethics, international regulatory systems, clinical trials and healthcare policies, quality assurance Good Laboratory Practice (GLP), Good Manufacturing Practices (GMP) and validation, intellectual property rights and the development and commercialization of drugs, biologics and medical devices. It is an interdisciplinary subject involving the application of chemistry, biology and technology. Topics included in the course are cosmetic technology, herbal medicines, pharmacological screening, clinical trials, medical and scientific writing and nutraceuticals. Candidates will have diverse knowledge about the preparation of medicines, diet required for different medications, laboratory testing and research of novel medications and methods of analysis of different drugs. Special emphasis is provided regarding major government agencies like US Food and Drug Administration (USFDA-US), European Directorate for the Quality of Medicines (EDQM-Europe), Therapeutic Goods Administration (TGA-Australia), Medicines and Healthcare products Regulatory Agency (MHRA-UK) and Therapeutic Products Directorate (TPD-Canada). Skills like analytical reasoning, presentation, computers, decision-making, problem-solving and entrepreneurship are enhanced through dissertations, projects, presentations, internships, publications and viva voce included in this course.
M Pharm Drug Regulatory Affairs course details
| Duration | 2 Years |
|---|---|
| Level | Master Programme |
| Admission Mode | Merit/Management |
| Entrance Exams | PGCET |
| Fee Detail | Merit Quota Seats :- Rs.50,000 to Rs.1,00,000 |
| Management Quota Seats :- Rs.1,00,000 to Rs.2,50,000 | |
| Admission Process: |
Merit- Students looking for Merit seats can go with KEA counseling for Admission Management- Students looking for Management seats can go for Direct Admission. |
List of Top M Pharm Drug Regulatory Affairs Colleges in Bangalore
-
Acharya and B.M. Reddy College of Pharmacy
![Acharya and B.M. Reddy College of Pharmacy]()
Course name: M Pharm Drug Regulatory Affairs
Affiliations:
Rajiv Gandhi University of Health Sciences (RGUHS)
Eligibility: Pass in B.Pharm degree from any university recognised as equivalent by RGUHS / PCI and AICTE with the minimum of 55% aggregate.
Duration: 2 years, Full Time, Post graduate Programme
Campus Location: Acharya Dr. Sarvepalli Radhakrishnan Road Acharya PO, Soladevanahalli Bangalore-560 107, India
Distance:
- The College is well connected to Bus stations, airport and railway station
- Distance from airport is 35.6 km
- Distance from Central bangalore Railway Station(SBC) is 21.8 km
- Distance from Yeswanthpur Railway Station is 14.5 km
List of M Pharm Drug Regulatory Affairs colleges
Placement of M Pharm Drug Regulatory Affairs
Career opportunities are available in healthcare centres, chemist shops, drug control administration units, hospitals and colleges/universities. Potential career roles:
- Teacher/Professor/Lecturer
- Research Associate
- Pharmacist
- Pharmacologist
- Medical Transcriptionist
- Health Care Unit Manager
- Lab Technician
- Drug Inspector
- Drug Regulator
- Quality Assurance Inspector
- Business Development Executive
- Medical Coder
- Clinical Data Manager
- Clinical Research Coordinator
- Pharmaceutical Validation Analyst
- Dispensary Manager
- Medicines Safety Manager
- Regulatory Affairs Consultant
- Regulatory Affairs Specialist
- Regulatory Affairs Associate
- Medical Affairs Associate
Top Recruiters for M Pharm Drug Regulatory Affairs students
Popular Recruiters:
- Schools/Colleges
- Research Institutions
- Lupin
- Cipla Inc.
- Piramal
- Biocon
- Sun Pharmaceuticals
- Aurobindo Pharma
- Dr. Reddy’s Laboratories
- Pfizer
- GlaxoSmithKline
- Johnson and Johnson
- Amgen
- Merck
- AstraZeneca
- Novartis
- Syngene
- Glenmark Pharma
- Zydus Cadila
- Novo Nordisk Inc.
- GVK Bio
